Tecvayli monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma predominantly refractory to anti-CD38 therapy and lenalidomide
Tecvayli monotherapy demonstrates superior progression-free and overal…
2 个月之前
marketscreener.com
Johnson & Johnson's TAR-200 monotherapy demonstrates highest complete response rate with sustained clinical benefits in patients with certain types of bladder cancer
Johnson & Johnson's TAR-200 monotherapy demonstrates highest c…
11 个月之前
finanznachrichten.de
Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer
Clinical evidence driving guideline recommendations for monotherapy i…
2024年12月20日
reachmd.com
First results of nivolumab plus ipilimumab vs nivolumab monotherapy for microsatellite instability high/ mismatch repair-deficient metastatic colorectal cancer from CheckMate 8HW | OncLive
10:33
First results of nivolumab plus ipilimumab vs nivolumab monothera…
2025年2月6日
onclive.com
Use of monotherapy (IO or TKI) or localized treatment in First Line | OncLive
Use of monotherapy (IO or TKI) or localized treatment in First Line | Onc…
2024年10月18日
onclive.com
Imugene doses first patient in intravenous monotherapy arm of Phase 1 clinical trial
Imugene doses first patient in intravenous monotherapy arm of Pha…
2024年2月15日
proactiveinvestors.com
New Nonstatin Cholesterol Lowering Drugs: How to Use Them
New Nonstatin Cholesterol Lowering Drugs: How to Use Them
2022年9月27日
medscape.com
Lifileucel TIL Cell Monotherapy in Patients With Advanced Melanoma …
2023年2月20日
onclive.com
EEG changes induced by vigabatrin monotherapy in focal epilepsy, Acta …
2014年12月16日
deepdyve.com
Dr Singer on Systemic Pembrolizumab Monotherapy in BCG-unresponsive …
2023年5月2日
onclive.com
Clinical Considerations for Monotherapy vs Dual Therapy in AT…
2 个月之前
hcplive.com
Evaluating I-O Monotherapy's Value in Treating mRCC | OncLive
1 个月前
onclive.com
Efficacy of Nivo Monotherapy in 1L Treatment-Resistant Advanced HC…
6 个月之前
vumedi.com
Combination Therapy vs Monotherapy in RA
2022年6月22日
medscape.com
Hutchmed Begins Phase 1 Study of HMPL-A251 Monotherapy to Treat P…
3 个月之前
marketscreener.com
Dr. Tombal on Darolutamide Monotherapy in Newly Diagnosed m…
2023年3月8日
onclive.com
The Efficacy and Safety Associated with Switching from Concomitant Bri…
2022年2月15日
jove.com
Dr. Ramaswamy on Capecitabine and Irinotecan Monotherapy in Gallbladd…
2020年7月2日
onclive.com
13:25
A First-in-Human, Phase 1a/b, Dose-Escalation/Expansion Study of BG-6…
9 个月之前
onclive.com
ROSELLA: A Phase 3 Study of Relacorilant in Combination With Na…
9 个月之前
onclive.com
Comparison of Nationally Representative Samples of Rasburic…
2022年10月14日
onclive.com
Biomed Industries Advances NA-931 Into Two Global Phase 3 Trials Alon…
2 个月之前
jacksonville.com
Biomed Industries Advances NA-931 Into Two Global Phase 3 Trials Alon…
3 个月之前
einpresswire.com
VIDEO: Relacorilant combination may improve survival for patients with ova…
9 个月之前
healio.com
Protocol AC: Step Therapy in DME - Eyetube
2023年4月17日
eyetube.net
Satralizumab: A Review in Neuromyelitis Optica Spectrum Disor…
2023年3月18日
springer.com
Combination Therapy: A New Frontline Standard in the Treatment of EGFR-…
11 个月之前
onclive.com
Levodopa
2022年8月12日
parkinson.org
Debates in CLL: The Case for BTKi Monotherapy in 1L
3 周前
vumedi.com
9:17
Frontline Treatments for KRAS G12C-Mutation mNSCLC | OncLive
1 个月前
onclive.com
观看更多视频
静态缩略图占位符